The Patent Finder

Anti-Extravasation Catheter

Cannuflow, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,357,126Anti-Extravasation Catheter
In force
 · High confidence
Cannuflow, Inc.In force
High confidence
US 8,647,322Anti-Extravasation Catheter
Lapsed Feb 11, 2026 on the fee record
Ended Feb 11, 2026 · High confidence
Cannuflow, Inc.Lapsed Feb 11, 2026 on the fee recordEnded Feb 11, 2026
High confidence
US 10,456,510Anti-Extravasation Catheter
Term ended
Term ended Oct 24, 2026 · High confidence
Cannuflow, Inc.Term endedTerm ended Oct 24, 2026
High confidence
Application 16/666,120Anti-Extravasation Catheter
Abandoned
Abandoned Mar 7, 2022
Cannuflow, Inc.AbandonedAbandoned Mar 7, 2022
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Cannuflow, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited